Screener
NeoGenomics NEO Reportable Segment — Income tax expense (benefit)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income | (17) | 482 | (29) | 547 |
| Gain on extinguishment of debt (Note 6) | 11,181 | — | 11,181 | — |
| Income (loss) before taxes | 1,826 | (45,816) | (15,752) | (71,473) |
| Income tax benefit | 412 | 724 | 884 | 458 |
| Net income (loss) | $2,238 | $(45,092) | $(14,868) | $(71,015) |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's reportable segment — income tax expense (benefit)?
- NeoGenomics (NEO) reported reportable segment — income tax expense (benefit) of -$412K in Q2 2026.
- How has NeoGenomics's reportable segment — income tax expense (benefit) changed year-over-year?
- NeoGenomics's reportable segment — income tax expense (benefit) increased by 43.1% year-over-year, from -$724K to -$412K.
- What is the long-term trend for NeoGenomics's reportable segment — income tax expense (benefit)?
- Over 3 years (2022 to 2025), NeoGenomics's reportable segment — income tax expense (benefit) has grown at a -47.0% compound annual growth rate (CAGR), from -$15.09M to -$2.24M.
- What does reportable segment — income tax expense (benefit) mean?
- This represents the tax provision or benefit allocated to the reportable segment based on its pre-tax earnings or losses. It reflects the impact of statutory tax rates and tax planning strategies on the segment's bottom-line performance.
Ask your AI about NeoGenomics's reportable segment — income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude